Paul-Henri Lambert

Former Director of ADVAC
Centre of Vaccinology, Department of Pathology and Immunology at University of Geneva

Switzerland

Paul-Henri Lambert, MD, is now associated as Senior Adviser with the Centre of Vaccinology in the Department of Pathology and Immunology at University of Geneva. He is particularly interested in vaccination strategies and evaluation of adverse effects. He is Senior Adviser, member of the Scientific Board and former director (2000-2018) of the International Advanced Course of Vaccinology (ADVAC). He is former chairman of the WHO Global Advisory Committee for Vaccine Safety (GACVS) and of the Human Vaccine Committee of the International Association for Biologicals (IABS).

Paul Henri Lambert is a native of Belgium. He obtained his MD and certification in Internal Medicine at University of Liege. He performed his post-graduate training in immunology with Frank Dixon at Scripps Institute, La Jolla, California, then moved to University of Geneva Medical School where he became professor in the Departments of Medicine and of Pathology. His research activities lead him to decipher immunological mechanisms involved in autoimmune and immune complex-mediated diseases, in the pathogenesis of malaria and in new strategies to optimize vaccine immunogenicity.

In 1987, he was appointed as chief Microbiology and Immunology at the World Health Organization and in 1994, Chief, Vaccine Research and Development, WHO Global Program for Vaccines and Immunization. He was then deeply involved in co-ordination of research aiming at the development of vaccines against diseases of major importance in developing countries. Paul-Henri Lambert is author or co-author of 480 publications, member of several international scientific boards, foreign member of the Royal Academy of Medicine in Belgium and Fellow of the American Association for the Advancement of Science.